BiotechTube
Home/Precision Neuroscience/Michael Mager
MM

Michael Mager

CEO & Co-Founder

Precision Neuroscience

Therapeutic Areas

Neurological DisordersParalysisEpilepsy

Precision Neuroscience Pipeline

DrugIndicationPhase
Layer 7 Cortical Interface for ParalysisCommunication & Device Control for Paralysis (e.g., spinal cord injury, ALS)Feasibility/Clinical Research
Layer 7 Cortical Interface for EpilepsyPre-surgical Epilepsy Monitoring and MappingFeasibility/Clinical Research

Leadership Team at Precision Neuroscience

BO
Brian Otis
Chief Technology Officer
View full Precision Neuroscience profile